Drug intelligence / Profile preview

neomycin sulfate + hydrocortisone + bacitracin zinc + polymyxin b

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Ophthalmic, Topical
01

Overview

Neomycin sulfate + hydrocortisone + bacitracin zinc + polymyxin b is a marketed **combination ophthalmic ointment** that combines three topical antibiotics with a corticosteroid for **steroid-responsive inflammatory ocular conditions when bacterial infection is present or there is a risk of bacterial infection**. The antibacterial components act through complementary mechanisms: **neomycin** binds the bacterial ribosome and inhibits protein synthesis, **polymyxin b** disrupts susceptible bacterial cell membranes, and **bacitracin zinc** inhibits bacterial cell wall synthesis; **hydrocortisone** activates the glucocorticoid receptor to suppress ocular inflammation. The product has been marketed under the brand **Cortisporin** and is indicated for inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, including infective conjunctivitis, chronic anterior uveitis, and ocular injury from chemical, thermal, or radiation burns or foreign body penetration.

Brand names
Cortisporin
Other names
neomycin and polymyxin b sulfates + bacitracin zinc + hydrocortisone ophthalmic ointmentneomycin sulfate + hydrocortisone + bacitracin zinc + polymyxin b ophthalmic ointment
02

Targets

Bacterial peptidoglycan biosynthesis pathwayBacterial RibosomeGR (Glucocorticoid receptor)

Beyond the preview

Go deeper on neomycin sulfate + hydrocortisone + bacitracin zinc + polymyxin b.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neomycin sulfate + hydrocortisone + bacitracin zinc + polymyxin b.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call